Caring Brands announces five issued U.S. patents for Hair Enzyme Booster and Photocil; Nasdaq delisting appeal ongoing

Caring Brands, Inc.

Five issued U.S. patents now protect two core platforms: Hair Enzyme Booster (4 patents) and Photocil (1 patent).
Hair Enzyme Booster targets $1.8B+ market; up to 50-60% of minoxidil users have low scalp enzyme levels.
Photocil targets $20B+ dermatology market; addresses psoriasis and vitiligo patients needing safe phototherapy.
Company is not in compliance with Nasdaq stockholders' equity requirement; delisting determination appealed.
Commercialization strategy includes B2B licensing, DTC via Amazon, and existing partnership with Taisho Pharmaceutical.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.